Skip to results
Modify your search
NARROW
1-20 of 30
Authors: Jeffrey Lipman
Journal Article
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3026–3034, https://doi.org/10.1093/jac/dkac273
Published: 29 August 2022
Journal Article
Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 8, August 2022, Pages 2227–2237, https://doi.org/10.1093/jac/dkac168
Published: 09 June 2022
Journal Article
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 9, September 2020, Pages 2633–2640, https://doi.org/10.1093/jac/dkaa211
Published: 25 June 2020
Journal Article
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 9, September 2020, Pages 2641–2649, https://doi.org/10.1093/jac/dkaa187
Published: 22 May 2020
Journal Article
β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 2, February 2020, Pages 429–433, https://doi.org/10.1093/jac/dkz437
Published: 26 October 2019
Journal Article
Defining optimal dosing of ciprofloxacin in patients with septic shock
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1662–1669, https://doi.org/10.1093/jac/dkz069
Published: 26 February 2019
Journal Article
Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 2, February 2019, Pages 432–441, https://doi.org/10.1093/jac/dky434
Published: 30 October 2018
Journal Article
EDITOR'S CHOICE
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 11, November 2018, Pages 3087–3094, https://doi.org/10.1093/jac/dky314
Published: 17 August 2018
Journal Article
Pharmacokinetics of piperacillin in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 6, June 2018, Pages 1647–1650, https://doi.org/10.1093/jac/dky057
Published: 01 March 2018
Journal Article
Maximally effective dosing regimens of meropenem in patients with septic shock
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 1, January 2018, Pages 191–198, https://doi.org/10.1093/jac/dkx330
Published: 12 September 2017
Journal Article
Effect of different renal function on antibacterial effects of piperacillin against Pseudomonas aeruginosa evaluated via the hollow-fibre infection model and mechanism-based modelling
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 9, September 2016, Pages 2509–2520, https://doi.org/10.1093/jac/dkw153
Published: 26 May 2016
Journal Article
Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 6, June 2016, Pages 1643–1650, https://doi.org/10.1093/jac/dkw043
Published: 07 March 2016
Journal Article
What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 3, March 2016, Pages 696–702, https://doi.org/10.1093/jac/dkv412
Published: 24 December 2015
Journal Article
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 1, January 2016, Pages 196–207, https://doi.org/10.1093/jac/dkv288
Published: 03 October 2015
Journal Article
Therapeutic drug monitoring of the β-lactam antibiotics: what is the evidence and which patients should we be using it for?
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 12, December 2015, Pages 3178–3183, https://doi.org/10.1093/jac/dkv201
Published: 17 July 2015
Journal Article
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 9, September 2015, Pages 2671–2677, https://doi.org/10.1093/jac/dkv165
Published: 13 July 2015
Journal Article
Plasma and target-site subcutaneous tissue population pharmacokinetics and dosing simulations of cefazolin in post-trauma critically ill patients Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 5, May 2015, Pages 1495–1502, https://doi.org/10.1093/jac/dku564
Published: 20 January 2015
Journal Article
Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy? Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 2, February 2015, Pages 528–533, https://doi.org/10.1093/jac/dku413
Published: 21 October 2014
Journal Article
Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 10, October 2014, Pages 2797–2803, https://doi.org/10.1093/jac/dku195
Published: 10 June 2014
Journal Article
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 9, September 2014, Pages 2508–2516, https://doi.org/10.1093/jac/dku177
Published: 30 May 2014
